PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.59M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
1.04%
Positive revenue growth while ADI is negative. John Neff might see a notable competitive edge here.
0.29%
Gross profit growth under 50% of ADI's 2.90%. Michael Burry would be concerned about a severe competitive disadvantage.
0.32%
Positive EBIT growth while ADI is negative. John Neff might see a substantial edge in operational management.
-0.96%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
297.09%
Positive net income growth while ADI is negative. John Neff might see a big relative performance advantage.
294.29%
Positive EPS growth while ADI is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
297.06%
Positive diluted EPS growth while ADI is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.20%
Share reduction while ADI is at 0.00%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.20%
Reduced diluted shares while ADI is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
0.20%
Maintaining or increasing dividends while ADI cut them. John Neff might see a strong edge in shareholder returns.
-42.35%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-45.64%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
56.33%
10Y revenue/share CAGR at 50-75% of ADI's 100.49%. Martin Whitman would question if the firm’s offerings lag behind the competitor.
47.90%
5Y revenue/share CAGR under 50% of ADI's 100.71%. Michael Burry would suspect a significant competitive gap or product weakness.
27.80%
3Y revenue/share CAGR under 50% of ADI's 65.90%. Michael Burry might see a serious short-term decline in relevance vs. the competitor.
134.19%
10Y OCF/share CAGR above 1.5x ADI's 77.56%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
247.85%
5Y OCF/share CAGR above 1.5x ADI's 102.32%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
94.00%
3Y OCF/share CAGR similar to ADI's 94.36%. Walter Schloss might see both benefiting from a rising tide or parallel expansions.
178.55%
Positive 10Y CAGR while ADI is negative. John Neff might see a substantial advantage in bottom-line trajectory.
324.95%
5Y net income/share CAGR above 1.5x ADI's 68.04%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
121.24%
3Y net income/share CAGR above 1.5x ADI's 26.52%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
45.75%
Below 50% of ADI's 258.52%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
9.43%
Below 50% of ADI's 96.78%. Michael Burry sees a substantially weaker mid-term book value expansion strategy in place.
9.04%
Below 50% of ADI's 81.57%. Michael Burry suspects a serious short-term disadvantage in building book value.
520.16%
10Y dividend/share CAGR above 1.5x ADI's 150.99%. David Dodd checks if the firm's robust cash flows justify outpacing the competitor's increases.
196.58%
5Y dividend/share CAGR above 1.5x ADI's 51.17%. David Dodd checks if the firm's mid-term cash flows justify a faster dividend growth rate.
82.35%
3Y dividend/share CAGR above 1.5x ADI's 22.17%. David Dodd sees a superior short-term capital return strategy if supported by stable earnings.
13.77%
AR growth well above ADI's 3.02%. Michael Burry fears inflated revenue or higher default risk in the near future.
3.83%
Inventory growth well above ADI's 1.62%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-0.77%
Both reduce assets yoy. Martin Whitman suspects a broader sector retraction or post-boom asset trimming cycle.
3.16%
BV/share growth above 1.5x ADI's 1.83%. David Dodd confirms if consistent profit retention or fewer write-downs yield faster equity creation.
0.02%
We have some new debt while ADI reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-0.26%
Our R&D shrinks while ADI invests at 5.43%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
5.87%
We expand SG&A while ADI cuts. John Neff might see the competitor as more cost-optimized unless we expect big payoffs from the overhead growth.